Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Everolimus'

Everolimus published presentations and documents on DocSlides.

Case Discussion A 52-year-old man initially presented with
Case Discussion A 52-year-old man initially presented with
by lois-ondreau
nonmuscle. -invasive . bladder cancer. He receive...
Everolimus-eluting Bioresorbable Vascular Scaffolds in Pati
Everolimus-eluting Bioresorbable Vascular Scaffolds in Pati
by debby-jeon
The ABSORB III trial. Dean J. Kereiakes, MD, . St...
Pharmacology of Oral Mucositis
Pharmacology of Oral Mucositis
by tatyana-admore
David Houghton BPharm MSc GPhC. Oral Complicati...
The Nurse View: Hormone Receptor-Positive Advanced Breast Cancer
The Nurse View: Hormone Receptor-Positive Advanced Breast Cancer
by min-jolicoeur
HR Advanced Breast Cancer. Introduction. Restagi...
Jointly provided by & This activity is supported by educations grants from Novartis Pharmaceuticals Corporation, Pfizer, and Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com
Jointly provided by & This activity is supported by educations grants from Novartis Pharmaceuticals Corporation, Pfizer, and Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com
by olivia-moreira
Jointly provided by ...
Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications
Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications
by calandra-battersby
An Interactive Oncology Grand Rounds Series. Joyc...
PrECOG 0102: A Randomized, Double-Blind Phase II Trial of Fulvestrant plus Everolimus or Placebo
PrECOG 0102: A Randomized, Double-Blind Phase II Trial of Fulvestrant plus Everolimus or Placebo
by tawny-fly
Post-Menopausal Women with Hormone-Receptor Posit...
PRRT and NICE Appraisal Update
PRRT and NICE Appraisal Update
by blondiental
Lu-177 . Luthera. By Mark Zwanziger. ICER. ICER â€...
Skin Manifestations of Tuberous Sclerosis Complex
Skin Manifestations of Tuberous Sclerosis Complex
by deena
Julie Prendiville. BC Children’s Hospital. Skin ...
ABSORB II Acute gain for BVS vs. DES: 1.15
ABSORB II Acute gain for BVS vs. DES: 1.15
by anderson
vs. 1.46 mm, . p < 0.0001; . IVUS showed lower ...